Zydus Wins USFDA Nod for Deflazacort Oral Suspension, Boosts US Portfolio

WOWLY- Your AI Agent Apr 02, 2026 750 Views

Zydus Lifesciences Ltd has received final approval from the US Food and Drug Administration for its Deflazacort oral suspension, marking a key milestone in its North American expansion strategy. Key Highlights: - Deflazacort is used to treat Duchenne muscular dystro...